首页> 外文期刊>Journal of applied microbiology >Effect of starter unit availability on the spectrum of manumycin-type metabolites produced by Streptomyces nodosus ssp. asukaensis.
【24h】

Effect of starter unit availability on the spectrum of manumycin-type metabolites produced by Streptomyces nodosus ssp. asukaensis.

机译:起动器单位可用性对结节链霉菌产生的manumycin型代谢物光谱的影响。 asukaensis

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Aims: Production of minor asukamycin congeners and its new derivatives by combination of targeted genetic manipulations with specific precursor feeding in the producer of asukamycin, Streptomyces nodosus ssp. asukaensis. Methods and Results: Structural variations of manumycins lie only in the diverse initiation of the 'upper' polyketide chain. Inactivation of the gene involved in the biosynthesis of cyclohexanecarboxylic acid (CHC) turned off the production of asukamycin in the mutant strain and allowed an increased production of other manumycins with the branched end of the upper chain. The ratio of produced metabolites was further affected by specific precursor feeding. Precursor-directed biosynthesis of a new asukamycin analogue (asukamycin I, 28%) with linear initiation of the upper chain was achieved by feeding norleucine to the mutant strain. Another asukamycin analogue with the unbranched upper chain (asukamycin H, 14%) was formed by the CHC-deficient strain expressing a heterologous gene putatively involved in the formation of the n-butyryl-CoA starter unit of manumycin A. Conclusions: Combination of the described techniques proved to be an efficient tool for the biosynthesis of minor or novel manumycins. Significance and Impact of the Study: Production of two novel asukamycin derivatives, asukamycins H and I, was achieved. Variations appeared in the upper polyketide chain, the major determinant of enzyme-inhibitory features of manumycins, affecting their cancerostatic or anti-inflammatory features.
机译:目的:通过有针对性的遗传操作与特定的前体饲喂相结合,在明日香霉素链霉菌 ssp的生产商中生产次明日香霉素同源物及其新衍生物。 asukaensis 。方法和结果:manumycins的结构变异仅在于“上部”聚酮化合物链的多样化起始。参与环己烷羧酸(CHC)生物合成的基因失活,关闭了突变菌株中明日霉素的生产,并增加了具有上链分支末端的其他manumycins的生产。产生的代谢物的比例进一步受到特定前体进料的影响。通过将正亮氨酸供入突变株中,可以实现前体定向的新的明日霉素类似物(明日霉素I,28%)的生物合成,上链呈线性起始。另一个具有直链上链的明日香霉素类似物(明日香霉素H,14%)是由CHC缺陷型菌株表达的,该菌株表达一种异源基因,该基因可能参与了manuycin的 n-butyryl-CoA启动子单元的形成。 A.结论:所描述的技术组合被证明是次要或新颖manumycins生物合成的有效工具。研究的意义和影响:实现了两种新型明日霉素衍生物H和I的生产。变异存在于上聚酮化合物链中,后者是manumycins的酶抑制特征的主要决定因素,影响了它们的抗癌或抗炎功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号